Search

  • HOME
  • Search
Correspondence
Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
Joo Hyun Oh, Dong Hyun Sinn
Clin Mol Hepatol. 2023;29(3):820-820.   Published online May 19, 2023
View: 1373   Download: 27
Original Article
1822
Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients
Xiaoning Wu, Xiaoqian Xu, Jialing Zhou, Yameng Sun, Huiguo Ding, Wen Xie, Guofeng Chen, Anlin Ma, HongXin Piao, Bingqiong Wang, Shuyan Chen, Tongtong Meng, Xiaojuan Ou, Hwai-I Yang, Jidong Jia, Yuanyuan Kong, Hong You
Clin Mol Hepatol. 2023;29(3):747-762.   Published online May 10, 2023
View: 1870   Download: 123
Editorial
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Clin Mol Hepatol. 2023;29(2):367-370.   Published online March 20, 2023
View: 2097   Download: 57  Web of Science: 3  Crossref: 2
Original Article
1607
Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
Lilian Yan Liang, Hye Won Lee, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip, Yee-Kit Tse, Vicki Wing-Ki Hui, Grace Chung-Yan Lui, Henry Lik-Yuen Chan, Grace Lai-Hung Wong
Clin Mol Hepatol. 2021;27(3):499-509.   Published online February 26, 2021
View: 4218   Download: 133  Web of Science: 13  Crossref: 13
Editorial
Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?
Ho Soo Chun, Minjong Lee
Clin Mol Hepatol. 2021;27(3):448-450.   Published online June 23, 2021
View: 3564   Download: 113
Original Article
1598
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial
Do Seon Song, Won Kim, Sang Hoon Ahn, Hyung Joon Yim, Jae Young Jang, Young Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Young Kul Jung, Joo Hyun Sohn, Jin-Woo Lee, Sung Jae Park, Byung Seok Lee, Ju Hyun Kim, Hong Soo Kim, Seung Kew Yoon, Moon Young Kim, Kwan Sik Lee, Young Suk Lim, Wan Sik Lee, Jin Mo Yang, Kyun-Hwan Kim, Kwang-Hyub Han, Soon Ho Um
Clin Mol Hepatol. 2021;27(2):346-359.   Published online January 25, 2021
View: 5210   Download: 228  Web of Science: 11  Crossref: 9
Editorial
Another oral antiviral treatment, but still far away from hepatitis B virus cure
Tai-Chung Tseng
Clin Mol Hepatol. 2021;27(2):281-282.   Published online March 10, 2021
View: 3344   Download: 98  Web of Science: 5  Crossref: 5
Review
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee
Clin Mol Hepatol. 2020;26(4):411-429.   Published online August 28, 2020
View: 14001   Download: 1,399  Web of Science: 64  Crossref: 61
Original Article
Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
Seung Ha Park, Lindsay D. Plank, Ki Tae Suk, Yong Eun Park, Jin Lee, Joon Hyuk Choi, Nae Yun Heo, Jongha Park, Tae Oh Kim, Young Soo Moon, Hyun Kuk Kim, Hang Jea Jang, Ha Young Park, Dong Joon Kim
Clin Mol Hepatol. 2020;26(2):209-215.   Published online November 4, 2019
View: 33432   Download: 399  Web of Science: 76  Crossref: 78
Review
1472
The fibrogenic process and the unleashing of acute-on-chronic liver failure
Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Natalia Nuño-Lámbarri
Clin Mol Hepatol. 2020;26(1):7-15.   Published online June 14, 2019
View: 10946   Download: 362  Web of Science: 9  Crossref: 10
Original Article
Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand
Ratchapong Laiwatthanapaisan, Pimsiri Sripongpun, Naichaya Chamroonkul, Arunee Dechaphunkul, Chirawadee Sathitruangsak, Siwat Sakdejayont, Chanon Kongkamol, Teerha Piratvisuth
Clin Mol Hepatol. 2019;25(4):366-373.   Published online July 17, 2019
View: 4953   Download: 106  Web of Science: 2  Crossref: 4
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Clin Mol Hepatol. 2019;25(3):283-293.   Published online November 13, 2018
View: 9655   Download: 236  Web of Science: 27  Crossref: 30
2
Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection
Yoon Jun Kim , Hyo Suk Lee
Clin Mol Hepatol. 2009;15(1):7-14.   Published online March 31, 2009
View: 5242   Download: 40  Crossref: 3
4
A case report of treatment with pegylated interferon alpha for Lamivudine-resistant chronic hepatitis B virus infection
Won Haing Hur , Hyun Young Woo , Soung Won Jeong , Chan Ran You , Si Hyun Bae , Jong Young Choi , Seung Kew Yoon
Clin Mol Hepatol. 2008;14(4):513-518.   Published online December 31, 2008
View: 4530   Download: 30
7
The Korean Journal of Entecavir 1 mg therapy for Lamivudine-refractory chronic hepatitis B
Hyung Joon Kim
Clin Mol Hepatol. 2008;14(3):411-416.   Published online September 30, 2008
View: 3720   Download: 15
The Korean Journal of Adefovir plus Lamivudine combination therapy in Lamivudine-resistant chronic hepatitis B
So Young Kwon
Clin Mol Hepatol. 2008;14(2):235-239.   Published online June 20, 2008
View: 3419   Download: 15
The Korean Journal of Normal range of serum ALT level in patients with chronic hepatitis
Yeon Seok Seo
Clin Mol Hepatol. 2008;14(1):116-121.   Published online March 20, 2008
View: 3990   Download: 18
3
Change of HBV DNA Level as a Predictor of HBeAg Loss after Lamivudine Treatment
Jae Kwon Jung, M.D., Chang Hyeong Lee, M.D., Eun Young Kim, M.D., Jin Tae Jung, M.D., Joon Hyuck Choi, M.D., Ji Min Han, M.D., Myoung In Jin, M.D., Ju Yeon Cho, M.D., Byung Seok Kim, M.D., Im Hee Shin, Ph.D.
Clin Mol Hepatol. 2007;13(4):513-520.   Published online December 20, 2007
View: 3558   Download: 28
The Efficacy and Safety of Telbivudine in Korean Patients with Chronic Hepatitis B
Young-Myoung Moon, M.D. Seong-Gyu Hwang, M.D. Boo-Sung Kim, M.D. Kyu-Sung Rim, M.D. Mong Cho, M.D. Dong-Joon Kim, M.D. Joon-Yeol Han, M.D. Young-Seok Kim, M.D. Ho-Soon Choi, M.D. Sang-Hoon Ahn, M.D.
Clin Mol Hepatol. 2007;13(4):503-512.   Published online December 20, 2007
View: 4398   Download: 29  Crossref: 6
Effect of Initial Virologic Response to Adefovir on the Development of Resistance to Adefovir in Lamivudine-resistant Chronic Hepatitis B
In Hee Kim , Seong Hun Kim , Hyun Chul Kim , Kyoung Deok Shin , Sang Wook Kim , Seong Ok Lee , Soo Teik Lee , Dae Ghon Kim
Clin Mol Hepatol. 2007;13(3):349-362.   Published online September 20, 2007
View: 3911   Download: 18  Crossref: 1
Predictors of Lamivudine Resistance in Patients with Chronic Hepatitis B Virus Infection
Jeong Heo , Mong Cho , Byung Mann Cho , Sun Mi Lee , Tae Oh Kim , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song
Clin Mol Hepatol. 2007;13(2):157-165.   Published online January 1, 1970
View: 2667   Download: 15
Clinical Outcomes of Lamivudine Therapy in HBeAg Positive Chronic Hepatitis B with Minimally Elevated ALT
Dong Ha Han , Neung Hwa Park , Jung Woo Shin , Seok Won Jung , Young Tae Hwang , Hyun Soo Kim , In Du Jeong , Sung Jo Bang , Do Ha Kim
Clin Mol Hepatol. 2007;13(2):146-156.   Published online January 1, 1970
View: 2650   Download: 20
Clinical Significances of Serum Soluble Fas and Soluble Fas Ligand in Chronic Hepatitis B
Eun Jung Jun, M.D., Joon-Yeol Han, M.D., and Hee Sik Sun, M.D.
Clin Mol Hepatol. 2006;12(4):507-514.   Published online January 1, 1970
View: 2613   Download: 20
2
Resistance to Adefovir in Patients with Chronic Hepatitis B
Soo Hyung Ryu, M.D.,* Young-Hwa Chung, M.D.
Clin Mol Hepatol. 2006;12(4):484-492.   Published online January 1, 2000
View: 2677   Download: 27
Correlation of HBV DNA Level and Viral Breakthrough During Lamivudine Therapy for Chronic Hepatitis B
Hee Seung Park , Dong Hyun Lee , Jeong Heo , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song , Mong Cho
Clin Mol Hepatol. 2006;12(2):173-183.   Published online January 1, 1970
View: 2644   Download: 22
Natural History of HBeAg Negative Chronic Hepatitis B Virus Infection; A Cohort Study
Chang Mo Moon, M.D., Do Young Kim, M.D., Ki Jun Song, Ph.D. Ja Kyung Kim, M.D., Hyun Woong Lee, M.D., Jung Min Lee, M.D., Ki Tae Yoon, M.D., Yong Han Paik, M.D., Dong Ki Kim, Ph.D. Kwang-Hyub Han, M.D., Chae Yoon Chon, M.D., Young Myoung Moon, M.D., and Sang Hoon Ahn, M.D.
Clin Mol Hepatol. 2006;12(2):163-172.   Published online January 1, 1970
View: 2229   Download: 26
2
Action Mechanism in Immunopathogenesis and Clearance of HBV
Se Jin Im , Young Chul Sung
Clin Mol Hepatol. 2006;12(2):154-162.   Published online January 1, 1970
View: 2680   Download: 47
1
Clinical Significance and Natural History of "HBeAg Negativity" in Patients with Chronic HBV Infection
Young Sok Lee
Clin Mol Hepatol. 2006;12(2):133-135.   Published online January 1, 1970
View: 2381   Download: 17
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 335
TOTAL : 1680900
Close layer